Bismuth subsalicylate for treatment of diarrhea
Pro Research Analysisby 
Searched over 200M research papers
Bismuth Subsalicylate for Diarrhea Treatment: Efficacy and Safety
Effectiveness in Acute and Chronic Diarrhea
Bismuth subsalicylate (BSS) has been shown to significantly reduce the duration and severity of acute diarrhea in both children and adults. Studies in hospitalized children with acute diarrhea found that BSS reduced stool frequency, improved stool consistency, shortened disease duration, and led to earlier hospital discharge compared to placebo, with no reported adverse effects and safe blood levels of bismuth and salicylate 18. In chronic diarrhea of childhood, BSS treatment resulted in fewer, firmer stools with less water content, and better weight gain compared to placebo .
Use in Traveler’s Diarrhea and Infectious Gastroenteritis
BSS is effective in both the treatment and prevention of traveler’s diarrhea. Multiple clinical trials have demonstrated that BSS reduces the number of unformed stools, improves subjective symptoms, and increases the proportion of patients free of symptoms at the end of treatment 2367. BSS has also been shown to be effective in preventing diarrhea caused by enterotoxigenic Escherichia coli, with studies reporting a significant reduction in the incidence of diarrhea among those taking BSS prophylactically 2910. The protective effect is apparent within a few days of starting BSS and is associated with fewer intestinal complaints and a lower rate of enteropathogen detection in stools .
Mechanisms of Action
The antidiarrheal effects of BSS are attributed to both its salicylate and bismuth components. The salicylate moiety provides antisecretory effects, while bismuth and its hydrolysis products have direct antimicrobial activity, particularly against pathogenic E. coli 249. BSS has been shown to clear pathogenic E. coli from stools in all treated cases in one study, though it did not affect rotavirus elimination .
Safety and Tolerability
Across multiple studies, BSS has been well tolerated with no significant adverse effects reported, even in infants and young children. Blood levels of bismuth and salicylate remained well below toxic thresholds in all studies reviewed 15810. Minor side effects, if any, were infrequent and mild .
Conclusion
Bismuth subsalicylate is a safe and effective adjunct to rehydration therapy for acute and chronic diarrhea in children, and it is also effective for the treatment and prevention of traveler’s diarrhea in adults. Its dual action—antisecretory and antimicrobial—makes it a valuable option for managing various types of diarrheal disease, with a strong safety profile and minimal risk of adverse effects 1235+5 MORE.
Sources and full results
Most relevant research papers on this topic